LBF20207PG62: Difference between revisions
(New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR1785 |LipidMaps=LMFA03010115 |SysName=(9alpha,11alpha,15S) -Trihydroxy-prosta- (5-cis,13-trans) -dien-1-oic acid, m...) |
No edit summary |
||
| Line 6: | Line 6: | ||
|LipidBank=XPR1785 | |LipidBank=XPR1785 | ||
|LipidMaps=LMFA03010115 | |LipidMaps=LMFA03010115 | ||
|SysName=(9alpha,11alpha,15S) -Trihydroxy-prosta- (5- | |SysName=(9alpha,11alpha,15S) -Trihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid, methyl ester | ||
|Common Name=&&Prostaglandin F_2 alpha methyl ester&&(9alpha,11alpha,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid, methyl ester&& | |Common Name=&&Prostaglandin F_2 alpha methyl ester&&(9alpha,11alpha,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid, methyl ester&& | ||
|Source= | |Source= | ||
Latest revision as of 08:43, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1785 |
| LipidMaps | LMFA03010115 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG62 |
| Prostaglandin F2α methyl ester | |
|---|---|
| |
| Structural Information | |
| (9α,11α,15S) -Trihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid, methyl ester | |
| |
| Formula | C21H36O5 |
| Exact Mass | 368.256274262 |
| Average Mass | 368.50754 |
| SMILES | C(CC[C@H](O)C=C[C@H]([C@H]1CC=CCCCC(OC)=O)[C@@H](C[C@@H]1O)O)CC |
| Physicochemical Information | |
| PGF2 alpha methyl ester is reported to have higher ocular hypotensive activity than PGF2 alpha with application to eyes of cats at 2.5 mu g of dose. Bito_LZ | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
